Clinical Trial Update: Treatment Of Dupuytren's Contracture With Collagenase Clostridium Histolyticum Injection (Xiapex) [Phase 3]

View source ↗

Summary

Phase 3 trial update on treating Dupuytren's Contracture with collagenase clostridium histolyticum injections (Xiapex); results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dupuytren Contracture

Drugs mentioned

• Xiapex (collagenase clostridium histolyticum)

Snippet

Sponsor: Pfizer | Conditions: Dupuytren's Contracture | Phase 3 | Status: COMPLETED | Results posted: 2014-03-17